Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients.
Marieke van der ZwanDennis A HesselinkEsther BrussePieter A van DoornMartijn W F van den HoogenAnnelies E de WeerdBart C JacobsPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)